Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor.
Anchoori RK, Anchoori V, Lam B, Tseng SH, Das S, Velasquez FC, Karanam B, Poddatoori D, Patnam R, Rudek MA, Chang YN, Roden RBS.
Anchoori RK, et al. Among authors: velasquez fc.
PLoS One. 2023 Jun 14;18(6):e0285221. doi: 10.1371/journal.pone.0285221. eCollection 2023.
PLoS One. 2023.
PMID: 37315065
Free PMC article.